- First quarter worldwide volume
growth of 9 percent compared to the prior year period.
- Adjusted EPS1 of $1.50
increased 18 percent as compared to the same period in the prior
year. Reported EPS of $0.74 primarily reflects a foreign exchange
loss for Venezuela and other items.
- Raises FY'14 adjusted2
diluted EPS guidance to a range of $6.10 to $6.30.
- Generated $191 million in operating
cash flow in first quarter 2014.
- Board of Directors takes steps to
accelerate cash returns to shareholders – terminates dividend,
determines to utilize cash instead to repurchase stock during the
second quarter.
Herbalife Ltd. (NYSE: HLF) today reported first quarter net
sales of $1.3 billion, reflecting an increase of 12 percent
compared to the same period in 2013 on volume point growth of 9
percent. Adjusted1 net income for the quarter was $151.1 million,
or $1.50 per diluted share, as compared to 2013 first quarter
adjusted net income of $137.4 million, or $1.27 per diluted share.
GAAP net income for the quarter was $74.6 million, or $0.74 per
diluted share, compared to $118.9 million, or $1.10 per diluted
share for the same period in 2013, primarily due to a foreign
exchange loss for Venezuela during the quarter ended March 31,
2014.
"We continue to achieve record earnings, strong sales growth and
enhanced profitability," said Michael O. Johnson, Herbalife's
chairman and CEO. “Our performance reflects the demand for our
exceptional products, as well as the hard work of our independent
members who continue to cultivate and grow their base of satisfied
customers worldwide. In addition, we are pleased to raise our
expectations for the balance of 2014. This reflects our confidence
that Herbalife is well-positioned to continue to grow and play an
increasingly important role in improving nutrition and reducing
obesity around the world.”
For the quarter ended March 31, 2014 the company generated cash
flow from operations of $190.6 million, an increase of 39 percent
compared to 2013; paid cash dividends of $30.4 million; invested
$49.7 million in capital expenditures; and spent $685.8 million for
approximately 9.9 million outstanding common shares under our
prepaid forward share repurchase agreement. As of April 25, 2014,
the company has spent $255 million during the month of April to
repurchase approximately 4.5 million outstanding common shares
under our existing repurchase program and pursuant to a Rule 10b5-1
trading plan.
As of March 31, 2014 we moved to the SICAD I rate of 10.7
Venezuelan bolivar per U.S. dollar for US GAAP remeasurement
purposes. This change impacted our 2014 Q1 reported results by
$89.3 million before tax and we have normalized this impact out of
our adjusted results.
First Quarter and Fiscal 2014 Key
Metrics3,4
Regional Volume Point and Average Active Sales Leader
Metrics
Volume Points (Mil) Average Active
Sales Leaders Region 1Q'14 Yr/Yr % Chg 1Q'14
Yr/Yr % Chg North America 336.5 9 % 74,241 9 % Asia Pacific
302.1 (6 %) 71,627 4 % EMEA 202.2 25 % 54,113 17 % Mexico 220.2 7 %
63,568 6 % South & Central America 227.7 4 % 61,862 19 % China
91.1 91 % 16,648 40 %
Worldwide Total 1,379.8
9 % 329,902 11 %
2014 Second Quarter and Full Year Guidance
Forward guidance excludes the impact of expenses (primarily for
legal and advisory services) relating to the company's response to
information put into the marketplace by a short seller, which the
company believes to be inaccurate and misleading, expenses related
to a FTC inquiry, and the impact of non-cash interest costs
associated with the company’s Convertible Notes. Forward guidance
is based on the average daily exchange rates of the first two weeks
of April. Included in the guidance is the use of the GAAP rate for
Venezuela of 10.7 to 1 for the balance of the year and excludes the
potential impact of future devaluation of the Venezuelan bolivar
and future repatriation, if any, of existing cash balances in
Venezuela.
Three Months Ending Twelve Months Ending
June 30,
2014 December 31, 2014 Low
High Low High Volume
Point Growth vs 2013 7.0 % 9.0 % 8.0 % 10.0 % Net Sales Growth vs
2013 10.0 % 12.0 % 10.0 % 12.0 % Diluted EPS as adjusted $ 1.51 $
1.55 $ 6.10 $ 6.30 Cap Ex ($ millions) $ 55.0 $ 65.0 $ 175.0 $
195.0 Effective Tax Rate 28.0 % 30.0 % 28.0 % 30.0 %
Board of Directors Accelerates Cash Returns to
Shareholders
The company’s board of directors also announced today that, as
part of its goal to accelerate cash returns to shareholders, it has
approved terminating the company’s quarterly cash dividend and
instead utilizing the cash to repurchase additional shares of the
company’s outstanding common stock during the second quarter of
2014.
The company now expects to repurchase a total of $581 million of
its outstanding common stock during the second quarter of 2014 as
part of its previously announced $1.5 billion share repurchase
program. The $581 million is comprised of the approximately $315
million expected to be purchased in April as part of a 10b5-1
trading plan ($255 million already completed as of Friday, April
25); plus the $50 million included in previous guidance and $216
million that otherwise was expected to be returned to shareholders
in the form of quarterly cash dividends over the next eight
quarters.
Mr. Johnson stated, “Our strong sustained financial performance
and the current market valuation of our shares make repurchasing
stock the most attractive method of returning capital to
shareholders and reflects our continued commitment to creating
long-term value for our shareholders.”
First Quarter Earnings Conference Call
Herbalife senior management will host an investor conference
call to discuss its recent financial results and provide an update
on current business trends on Tuesday, April 29, 2014 at 8 a.m. PDT
(11 a.m. EDT).
The dial-in number for this conference call for domestic callers
is (877) 317-1296 and (706) 634-5671 for international callers
(conference ID 24490341). Live audio of the conference call will be
simultaneously webcast in the investor relations section of the
company's website at http://ir.herbalife.com.
An audio replay will be available following the completion of
the conference call in MP3 format or by dialing (855) 859-2056 for
domestic callers or (404) 537-3406 for international callers
(conference ID 24490341). The webcast of the teleconference will be
archived and available on Herbalife's website.
About Herbalife Ltd.
Herbalife Ltd. (NYSE:HLF) is a global nutrition company
that sells weight-management, nutrition and personal care products
intended to support a healthy lifestyle. Herbalife products are
sold in more than 90 countries to and through a network of
independent members. The company supports the Herbalife Family
Foundation and its Casa Herbalife program to help bring good
nutrition to children. Herbalife's website contains a significant
amount of financial and other information about the company at
http://ir.Herbalife.com. The company encourages investors to visit
its website from time to time, as information is updated and new
information is posted.
1 See Schedule A – “Reconciliation of Non-GAAP Financial
Measures” for more detail.2 Adjusted diluted EPS excludes non-cash
interest expense associated with the company’s Convertible Notes,
foreign exchange losses related to Venezuela, costs associated with
the FTC inquiry and the defense against misinformation associated
with a short seller.3 Supplemental tables that include additional
business metrics can be found at http://www.ir.herbalife.com.4
Worldwide Average Active Sales Leaders may not equal the sum of the
Average Active Sales Leaders in each region due to the calculation
being an average of Sales Leaders active in a period, not a
summation, and the fact that some Sales Leaders are active in more
than one region but are counted only once in the worldwide
amount.
FORWARD-LOOKING STATEMENTS
Although we believe that the expectations reflected in any of
our forward-looking statements are reasonable, actual results could
differ materially from those projected or assumed in any of our
forward-looking statements. Our future financial condition and
results of operations, as well as any forward-looking statements,
are subject to change and to inherent risks and uncertainties, such
as those disclosed or incorporated by reference in our filings with
the Securities and Exchange Commission. Important factors that
could cause our actual results, performance and achievements, or
industry results to differ materially from estimates or projections
contained in our forward-looking statements include, among others,
the following:
- our relationship with, and our ability
to influence the actions of, our Members;
- improper action by our employees or
Members in violation of applicable law;
- adverse publicity associated with our
products or network marketing organization, including our ability
to comfort the marketplace and regulators regarding our compliance
with applicable laws;
- changing consumer preferences and
demands;
- our reliance upon, or the loss or
departure of any member of, our senior management team which could
negatively impact our Member relations and operating results;
- the competitive nature of our
business;
- regulatory matters governing our
products, including potential governmental or regulatory actions
concerning the safety or efficacy of our products and network
marketing program, including the direct selling market in which we
operate;
- legal challenges to our network
marketing program;
- risks associated with operating
internationally and the effect of economic factors, including
foreign exchange, inflation, disruptions or conflicts with our
third party importers, pricing and currency devaluation risks,
especially in countries such as Venezuela;
- uncertainties relating to the
application of transfer pricing, duties, value added taxes, and
other tax regulations, and changes thereto;
- uncertainties relating to
interpretation and enforcement of legislation in China governing
direct selling;
- uncertainties relating to the
interpretation, enforcement or amendment of legislation in India
governing direct selling;
- our inability to obtain the necessary
licenses to expand our direct selling business in China;
- adverse changes in the Chinese economy,
Chinese legal system or Chinese governmental policies;
- our dependence on increased penetration
of existing markets;
- contractual limitations on our ability
to expand our business;
- our reliance on our information
technology infrastructure and outside manufacturers;
- the sufficiency of trademarks and other
intellectual property rights;
- product concentration;
- changes in tax laws, treaties or
regulations, or their interpretation;
- taxation relating to our Members;
- product liability claims;
- whether we will purchase any of our
shares in the open markets or otherwise; and
- share price volatility related to,
among other things, speculative trading and certain traders
shorting our common shares.
We do not undertake any obligation to update or release any
revisions to any forward-looking statement or to report any events
or circumstances after the date hereof or to reflect the occurrence
of unanticipated events, except as required by law.
RESULTS OF OPERATIONS:
Herbalife Ltd. and Subsidiaries Condensed
Consolidated Statements of Income (In thousands, except per share
amounts) (Unaudited) Three Months Ended
3/31/2014 3/31/2013 North America
$ 247,860 $ 221,473 Mexico 142,663 132,889 South and Central
America 244,623 219,515 EMEA 211,135 169,585 Asia Pacific 280,496
311,747 China 135,872 68,438 Worldwide net sales
1,262,649 1,123,647 Cost of Sales 251,165 225,977
Gross Profit 1,011,484 897,670 Royalty Overrides 381,819 364,029
Selling, General and Administrative Expenses (1) 502,062
364,720 Operating Income 127,603 168,921 Interest Expense,
net 14,961 5,373 Other Expense, net (1) 3,161 -
Income before income taxes 109,481 163,548 Income Taxes
34,853 44,675 Net Income 74,628 118,873
Basic Shares 95,397 104,121 Diluted Shares 100,780 108,068
Basic EPS $ 0.78 $ 1.14 Diluted EPS $ 0.74 $ 1.10 Dividends
declared per share $ 0.30 $ 0.30
(1) As discussed in Note 2 of the
quarterly report on Form 10-Q for the quarter ended March 31, 2014,
Selling, General and Administrative Expenses and Other Expense, net
for the three months ended March 31, 2014 includes an $89.3 million
pre-tax unfavorable impact related to the remeasurement of
Venezuela Bolivar-denominated assets and liabilities at the SICAD I
rate of 10.7 Venezuela Bolivars per U.S. dollar.
Herbalife Ltd. and Subsidiaries Condensed Consolidated
Balance Sheets (In thousands) (Unaudited) Mar 31, Dec
31,
2014 2013
ASSETS Current Assets: Cash & cash equivalents $
1,261,921 $ 972,974 Receivables, net 118,610 100,326 Inventories
324,992 351,201 Prepaid expenses and other current assets 162,842
148,774 Deferred income taxes 67,739 69,845
Total Current Assets 1,936,104 1,643,120 Property,
net 346,363 318,860 Deferred compensation plan assets 26,969 26,821
Deferred financing cost, net 27,367 4,896 Other assets 103,567
63,713 Marketing related intangibles and other intangible assets,
net 310,729 310,801 Goodwill 105,490 105,490
Total Assets $ 2,856,589 $ 2,473,701
LIABILITIES AND SHAREHOLDERS' EQUITY Current Liabilities:
Accounts payable $ 87,174 $ 82,665 Royalty overrides 259,758
266,952 Accrued compensation 74,940 111,905 Accrued expenses
276,532 267,501 Current portion of long-term debt 87,509 81,250
Advance sales deposits 83,592 68,079 Income taxes payable
32,400 43,826 Total Current Liabilities
901,905 922,178 Non-current liabilities Long-term debt, net
of current portion 1,760,778 850,019 Deferred compensation plan
liability 40,523 37,226 Deferred income taxes 63,182 66,026 Other
non-current liabilities 48,095 46,806
Total Liabilities 2,814,483 1,922,255 Contingencies
Shareholders' equity: Common shares 101 101 Paid-in capital in
excess of par value 423,515 323,860 Accumulated other comprehensive
loss (22,485 ) (19,794 ) (Accumulated deficit) retained earnings
(359,025 ) 247,279 Total Shareholders' Equity
42,106 551,446 Total
Liabilities and Shareholders' Equity $ 2,856,589 $ 2,473,701
Herbalife Ltd. and Subsidiaries
Condensed Consolidated Statements of Cash Flows (In thousands)
(Unaudited) Three Months Ended
3/31/2014
3/31/2013 CASH FLOWS FROM
OPERATING ACTIVITIES Net income $ 74,628 $ 118,873 Adjustments to
reconcile net income to net cash provided by operating activities:
Depreciation and amortization 21,283 20,964 Excess tax benefits
from share-based payment arrangements (3,154 ) (447 ) Share based
compensation expenses 10,995 7,866 Non-cash interest expense and
amortization of deferred financing and issuance costs 7,154 650
Deferred income taxes (2,313 ) (3,773 ) Inventory write-downs
11,037 6,554 Unrealized foreign exchange transaction loss (gain)
3,390 (10,971 ) Foreign exchange loss relating to Venezuela 86,108
15,116 Other 4,462 (890 ) Changes in operating assets and
liabilities: Receivables (17,953 ) 3,216 Inventories 14,198 (1,542
) Prepaid expenses and other current assets (23,850 ) (8,200 )
Other assets (5,180 ) (15 ) Accounts payable 6,224 4,900 Royalty
overrides (3,703 ) (21,472 ) Accrued expenses and accrued
compensation (12,487 ) (15,517 ) Advance sales deposits 17,416
(3,857 ) Income taxes (903 ) 23,097 Deferred compensation plan
liability 3,297 3,075 NET CASH PROVIDED
BY OPERATING ACTIVITIES 190,649 137,627
CASH FLOWS FROM INVESTING ACTIVITIES Purchases of property, plant
and equipment (58,517 ) (24,856 ) Proceeds from sale of property,
plant and equipment 2 24 Investments in Venezuelan bonds
(3,224 ) - NET CASH USED IN INVESTING ACTIVITIES
(61,739 ) (24,832 ) CASH FLOWS FROM FINANCING
ACTIVITIES Dividends paid (30,399 ) (30,904 ) Dividends received
3,444 - Payments for capped call transactions (123,825 ) -
Borrowings from long-term debt 1,150,000 513,223 Principal payments
on long-term debt (18,750 ) (25,509 ) Debt issuance costs (28,837 )
- Share repurchases (694,503 ) (164,485 ) Excess tax benefits from
share-based payment arrangements 3,154 447 Proceeds from exercise
of stock options and sale of stock under employee stock purchase
plan 60 425 NET CASH PROVIDED BY
FINANCING ACTIVITIES 260,344 293,197
EFFECT OF EXCHANGE RATE CHANGES ON CASH (100,307 )
(17,052 ) NET CHANGE IN CASH AND CASH EQUIVALENTS 288,947 388,940
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 972,974
333,534 CASH AND CASH EQUIVALENTS, END OF
PERIOD 1,261,921 722,474 CASH PAID
DURING THE PERIOD Interest paid $ 7,533 $ 5,486
Income taxes paid $ 39,403 $ 31,853 NON CASH
ACTIVITIES Accrued capital expenditures $ 20,452 $ 10,070
SUPPLEMENTAL INFORMATION
SCHEDULE A: RECONCILIATION OF NON-GAAP FINANCIAL
MEASURES(unaudited and unreviewed), (dollars in thousands,
except per share data)
In addition to its reported results, the company has included
in the tables below adjusted results that the Securities and
Exchange Commission defines as “non-GAAP financial measures.”
Management believes that such non-GAAP financial measures, when
read in conjunction with the company’s reported results, can
provide useful supplemental information for investors in analyzing
period to period comparisons of the company’s results.
The following is a reconciliation of net income, presented and
reported in accordance with U.S. generally accepted accounting
principles, to net income adjusted for certain items:
Three Months Ended 3/31/2014
3/31/2013 (in thousands) Net income, as reported $ 74,628 $
118,873 Remeasurement loss relating to Venezuela (1)(2) 66,602
10,524 Expenses incurred responding to attacks on the Company's
business model (1)(3) 3,307 7,979 Expenses related to the FTC
inquiry (1)(4) 670 - Non-cash interest expense and amortization of
non-cash issuance costs (5) 5,843 - Net income, as
adjusted $ 151,050 $ 137,376
The following is a reconciliation of diluted earnings
per share, presented and reported in accordance with U.S. generally
accepted accounting principles, to diluted earnings per share
adjusted for certain items:
Three Months Ended 3/31/2014 3/31/2013 Diluted
earnings per share, as reported $ 0.74 $ 1.10 Remeasurement loss
relating to Venezuela (1)(2) 0.66 0.10 Expenses incurred responding
to attacks on the Company's business model (1)(3) 0.03 0.07
Expenses related to the FTC inquiry (1)(4) 0.01 - Non-cash interest
expense and amortization of non-cash issuance costs (5) 0.06
- Diluted earnings per share, as adjusted $ 1.50 $ 1.27
(1) Based on interim income tax reporting
rules, these expenses are not considered discrete items. As a
result, the company's 2014 full year effective tax rate is impacted
by these items. When applying the full year effective tax rate to
year-to-date income, the company's year-to-date tax provision
recorded with respect to these non-GAAP adjustments is different
from the forecasted full-year tax provision impact of these items.
As a consequence, adjustments to the year-to-date and quarterly tax
impacts will be recorded as the adjusted full year effective tax
rate is applied to income in subsequent periods. Additionally,
adjustments to items unrelated to these non-GAAP adjustments may
have an effect on the income tax impact of these non-GAAP
adjustments in subsequent periods. The company plans to update the
income tax impact of these items in subsequent interim reporting
periods.
(2) Net of $22,666 and $4,591 tax benefit for the three months
ended March 31, 2014 and 2013, respectively. (3) Net of $995 and
$1,515 tax benefit for the three months ended March 31, 2014 and
2013, respectively. (4) Net of $240 tax benefit for the three
months ended March 31, 2014. (5) Relates to non-cash expense on our
convertible notes and prepaid forward share repurchase contract
The following is a reconciliation of total long-term debt to net
debt:
3/31/2014 12/31/2013
Total long-term debt (current and long-term portion) $ 1,848,287 $
931,269 Less: Cash and cash equivalents 1,261,921
972,974 Net debt $ 586,366 $ (41,705 )
Herbalife Ltd.Media Contact:Barbara HendersonSVP, Worldwide
Corp. Comm.213.745.0517orInvestor Contact:Amy GreeneVP, Investor
Relations213.745.0474
Herbalife (NYSE:HLF)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Herbalife (NYSE:HLF)
Historical Stock Chart
Von Jul 2023 bis Jul 2024